Recent studies have reported aberrant methylation at Parkin promoter among acute lymphoid leukemia (ALL), chronic granulocytic leukemia (CGL) [15], nasopharyngeal carcinoma [22] and cervical cancer [9]. This evidence concerns the gene PRKN and acute lymphoblastic leukemia.